METHODS FOR MODULATION OF AND SENSITIZATION TO SERINE AND GLYCINE LIMITATION
Disclosed herein are formulations and methods of administering formulations to starve cells of nutrients, such as amino acids. The formulations of the present invention can be substantially be devoid of one or more amino acid. The formulations of the present invention can be administered in a combination with an amino acid biosynthesis inhibitor or radiotherapy. A method disclosed herein can sensitize a cell to serine and/or glycine depletion.
1 - 21 . (canceled)
22 . A method of treating a cancer in a subject in need thereof, the method comprising: a) administering to the subject a therapeutically-effective amount of a pharmaceutical composition for a first amount of time, wherein the pharmaceutical composition is substantially devoid of at least two amino acids; b) administering to the subject a radiation therapy for a second amount of time; and c) after the first amount of time and the second amount of time, waiting a third amount of time, wherein the subject is not administered the pharmaceutical composition or the radiotherapy during the third amount of time.
23 . The method of claim 22 , wherein the cancer is rectal cancer.
24 . The method of claim 22 , wherein the cancer is breast cancer.
25 . The method of claim 22 , wherein the administering of the pharmaceutical composition is oral.
26 . The method of claim 22 , wherein the radiation therapy is an external beam therapy.
27 . The method of claim 26 , wherein the external beam therapy is three dimensional conformal radiation therapy (3D-CRT).
28 . The method of claim 26 , wherein the external beam therapy is intensity-modulated radiation therapy (IMRT).
29 . The method of claim 22 , wherein the radiation therapy comprises administering about 5 Grays (Gy) to about 50 Gy of radiation to the subject.
30 . The method of claim 22 , wherein the radiation therapy is an internal beam therapy.
31 . The method of claim 22 , wherein the at least two amino acids is serine and glycine.
32 . The method of claim 31 , wherein the pharmaceutical composition is further substantially devoid of proline.
33 . The method of claim 22 , further comprising administering a high fat diet to the subject, wherein the high fat diet has greater than about 50% of daily calories from fat.
34 . The method of claim 22 , further comprising administering a low carbohydrate diet to the subject, wherein the low carbohydrate diet has less than about 50% of daily calories from carbohydrates.
35 . The method of claim 22 , further comprising administering a low carbohydrate diet to the subject, wherein the low carbohydrate diet has less than about 10% of daily calories from carbohydrates.
36 . The method of claim 22 , further comprising administering a low protein diet to the subject, wherein the low protein diet has less than about 15% of daily calories from whole protein.
37 . The method of claim 22 , further comprising administering a low protein diet to the subject, wherein the low protein diet has less than about 40 g/day of whole protein.
38 . The method of claim 22 , wherein the first amount of time and the second amount of time are equal.
39 . The method of claim 22 , wherein the first amount of time and the second amount of time are 5 days.
40 . The method of claim 22 , wherein the first amount of time and the second amount of time is greater than the third amount of time.
41 . The method of claim 40 , wherein the third amount of time is 2 days.
42 . The method of claim 22 , further comprising repeating steps a), b), and c).